Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

bloomberg.com - Dave Sebastian - Telix Pharma Upsizes Convertible Bond Deal to $600 Million
Telix Pharma Upsizes Convertible Bond Deal to $600 Million
Bloomberg

Telix Pharmaceuticals Ltd. raised $600 million from a convertible bond deal that fetched more than expected, in a sign of strong demand for Australia's largest yet such offering this year. The company's shares fell. The Melbourne, Australia-based…

globenewswire.com - Zealand Pharma - Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
GlobeNewswire

Press release – No. 7 / 2026  Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations Bringing significant experience from Vertex Pharmaceuticals and Shire Copenhagen, Denmark and Boston…

indianexpress.com - Ankita Upadhyay - Hormuz crisis may push up drug prices: Pharma MSMEs battle cost spike of raw materials, packaging
Hormuz crisis may push up drug prices: Pharma MSMEs battle cost spike of raw materials, packaging
The Indian Express

Disruptions in shipping routes have sharply raised input costs and triggered supply uncertainties for India's small-scale pharmaceutical manufacturers, who warn of cascading effects on medicine prices, availability and even quality. Several key…

marketbeat.com - Foster Victor Wealth Advisors LLC Takes Position in Royalty Pharma PLC $RPRX
Foster Victor Wealth Advisors LLC Takes Position in Royalty Pharma PLC $RPRX
MarketBeat

Foster Victor Wealth Advisors LLC acquired a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 180,657 shares of the biopharmaceutical…

marketbeat.com - NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Consensus Rating of 'Moderate Buy' from Analysts
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Consensus Rating of 'Moderate Buy' from Analysts
MarketBeat

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) has earned an average recommendation of 'Moderate Buy' from the twelve analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a…

marketbeat.com - Athira Pharma (NASDAQ:LONA) Shares Down 6.5% - Should You Sell?
Athira Pharma (NASDAQ:LONA) Shares Down 6.5% - Should You Sell?
MarketBeat

Shares of Athira Pharma, Inc. (NASDAQ:LONA - Get Free Report) traded down 6.5% during mid-day trading on Tuesday. The company traded as low as $9.06 and last traded at $9.07. 35,461 shares traded hands during trading, a decline of 51% from the…

marketbeat.com - Innate Pharma (OTCMKTS:IPHYF) Stock Price Up 9.3% - Here's What Happened
Innate Pharma (OTCMKTS:IPHYF) Stock Price Up 9.3% - Here's What Happened
MarketBeat

Innate Pharma SA (OTCMKTS:IPHYF - Get Free Report)'s stock price rose 9.3% during trading on Tuesday. The stock traded as high as $1.50 and last traded at $1.50. Approximately 1,000 shares traded hands during mid-day trading, an increase of 19,900%…

globenewswire.com - ALK Abello - neffy approved as the first needle-free anaphylaxis treatment of adults and children in Canada
neffy approved as the first needle-free anaphylaxis treatment of adults and children in Canada
GlobeNewswire

ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that Health Canada has approved neffy 2 mg for the emergency treatment of allergic reactions (anaphylaxis) due to insect stings or bites, foods, medicinal products and other allergens, as…

globenewswire.com - Nxera Pharma - Notice of Issuance of New Shares in Connection with the Introduction of the Employee Stock Ownership Plan, Matters Relating to Stock Units and Determination of Payment Amount and Other Matters of Issuance of New Shares Under Prior RSU Award
Notice of Issuance of New Shares in Connection with the Introduction of the Employee Stock Ownership Plan, Matters Relating to Stock Units and Determination of Payment Amount and Other Matters of Issuance of New Shares Under Prior RSU Award
GlobeNewswire

Tokyo, Japan and Cambridge, UK, 15 April 2026 – Nxera Pharma Co. Ltd (“Nxera” or the “Company”; TSE 4565) announces that, in connection with the introduction of the Employee Stock Ownership Plan for employees…

dailymail.co.uk - Emily Joshu Sterne, U.S. Assistant Health Editor - Cough drops sold nationwide recalled over undisclosed 'quality issues
Cough drops sold nationwide recalled over undisclosed 'quality issues
Mail Online

READ MORE: More than 350,000 vitamins and supplements recalled More than a dozen types of cough drops have been urgently recalled due to undisclosed 'quality issues.' China-based firm Xiamen Kang Zhongyuan Biotechnology Co., Ltd., voluntarily…

wsj.com - The Editorial Board - Opinion | Dr. Makary and Mr. Hyde at the FDA
Opinion | Dr. Makary and Mr. Hyde at the FDA
Wall Street Journal

Food and Drug Administration biologics chief Vinay Prasad is stepping down at the end of this month after torpedoing breakthrough rare disease treatments. The grim reaper can't leave soon enough, but he's not leaving without kicking patients with…

bangordailynews.com - Benjamin Kail - Disability rights group condemns Graham Platner's use of 'retarded' in interview
Disability rights group condemns Graham Platner's use of 'retarded' in interview
Bangor Daily News

Our political journalists are based in the Maine State House and have deep source networks across the partisan spectrum in communities all over the state. Their coverage aims to cut through major debates and probe how officials make decisions. Read…

news-medical.net - OBN rebrands to BioUK in alignment with its mission to
OBN rebrands to BioUK in alignment with its mission to
News-Medical

OBN (UK) Ltd., the not-for-profit membership organization focused on catalyzing success UK life sciences, today announced that it is changing its name to BioUK. This updated brand identity has been developed to align with the organization's…

dexerto.com - Inside the High On Life 2 trailer that breaks every rule of game marketing
Inside the High On Life 2 trailer that breaks every rule of game marketing
Dexerto

In an industry where game trailers are typically built around gameplay footage and cinematic cutscenes, the High On Life 2 trailer takes a different approach entirely. Created by Dexerto in collaboration with Squanch Games, the live-action spot…

fool.com - Motley Fool Transcribing - Becton Dickinson (BDX) Q4 2024 Earnings Transcript
Becton Dickinson (BDX) Q4 2024 Earnings Transcript
The Motley Fool

Thursday, November 7, 2024 at 8 a.m. ET Chairman, Chief Executive Officer, and President — Tom Polen Executive Vice President and Chief Financial Officer — Chris DelOrefice President, Medical Segment — Mike Garrison President…

Receive a Daily briefing on Pharma Industry News

Get Started